← Back to Search

Petrolatum with Non-Stick Gauze for Hidradenitis Suppurativa

N/A

Waitlist Available

Led By Franklin R Blum, BS

Research Sponsored by University of North Carolina, Chapel Hill

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up completed at 1, 2, 4 and 6 weeks post-surgery utilizing images submitted by patients

Awards & highlights

Study Summary

This trial is testing whether wet-to-dry dressings or petrolatum with non-stick bandaging is better for healing after hidradenitis suppurativa (HS) surgery.

Eligible Conditions

Hidradenitis Suppurativa
Surgical Wound

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ collected at 1, 2, 4 and 6 weeks post-surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~collected at 1, 2, 4 and 6 weeks post-surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at 1, 2, 4 and 6 weeks post-surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in PUSH Score Over Time

Change in Pain with Dressing Changes

Change in Wound QOL Survey Score Over Time

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Petrolatum with Non-Stick GauzeExperimental Treatment1 Intervention

Participants in this arm will receive petrolatum with non-stick gauze.

Group II: Wet-to-dry DressingsActive Control1 Intervention

Participants in this arm will receive standard of care wet-to-dry dressings.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Petrolatum with Non-Stick Gauze

2022

N/A

~80

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor

1,504 Previous Clinical Trials

4,187,582 Total Patients Enrolled

1 Trials studying Hidradenitis Suppurativa

32 Patients Enrolled for Hidradenitis Suppurativa

Christopher J Sayed, MDStudy DirectorUniversity of North Carolina, Chapel Hill

1 Previous Clinical Trials

32 Total Patients Enrolled

1 Trials studying Hidradenitis Suppurativa

32 Patients Enrolled for Hidradenitis Suppurativa

Franklin R Blum, BSPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Media Library

Petrolatum with Non-Stick Gauze Clinical Trial Eligibility Overview. Trial Name: NCT05194969 — N/A

Hidradenitis Suppurativa Research Study Groups: Petrolatum with Non-Stick Gauze, Wet-to-dry Dressings

Hidradenitis Suppurativa Clinical Trial 2023: Petrolatum with Non-Stick Gauze Highlights & Side Effects. Trial Name: NCT05194969 — N/A

Petrolatum with Non-Stick Gauze 2023 Treatment Timeline for Medical Study. Trial Name: NCT05194969 — N/A

Hidradenitis Suppurativa Patient Testimony for trial: Trial Name: NCT05194969 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitments currently underway for this clinical experiment?

"According to the information housed on clinicaltrials.gov, this research is currently seeking participants with its initial posting taking place on April 25th 2022 and most recent update occurring two days later."

Answered by AI

Is this clinical testing open to participants who are 45 or older?

"This research project is seeking individuals aged 16 and above, but not exceeding 99 years old."

Answered by AI

How many participants can be included in this research project?

"Affirmative. According to clinicaltrials.gov, this ongoing medical study is currently accepting participants since its launch on April 25th 2022 and the latest update was just two days later. 80 patients are required from at least one site."

Answered by AI

Can I participate in this research endeavor?

"Potential participants in this clinical trial must have a surgical wound and be between 16 to 99 years old. The recruitment goal is approximately 80 individuals."

Answered by AI